Navigation Links
ADVENTRX Receives Brand Name Acceptance for ANX-530
Date:3/12/2010

d in this press release that are not a description of historical facts are forward-looking statements that involve risks and assumptions that, if they materialize or do not prove to be accurate, could cause ADVENTRX's results to differ materially from historical results or those expressed or implied by such forward-looking statements.  These risks and uncertainties include, but are not limited to: the risk that FDA determines that there is a safety concern related to interchanging ANX-530 with other vinorelbine injectable products; the risk that the FDA's requirements for an ANX-530 NDA to be accepted for review do not justify continued development of ANX-530; ADVENTRX's dependence on the success of ANX-530, and increased uncertainty as to whether ANX-530 will receive regulatory approval or be commercialized successfully; the potential that FDA may not accept a resubmitted ANX-530 NDA for review, or that the bioequivalence data and other information included in the ANX-530 NDA may not adequately support bioequivalence with Navelbine; the potential that changes made in transferring the manufacturing process for ANX-530 may result in a lack of comparability between the commercial product and the material used in clinical trials, and that FDA may require ADVENTRX to perform additional non-clinical or clinical studies; the potential for FDA to impose other requirements to be completed before or after approval of the ANX-530 NDA; the risk that ADVENTRX will have insufficient capital to support its operations during the FDA review of an ANX-530 NDA, should a resubmitted ANX-530 be accepted; the risk that ADVENTRX will pursue development activities at levels or on timelines, or will incur unexpected expenses, that shortens the period through which its operating funds will sustain it; the risk that ADVENTRX will be unable to raise sufficient additional capital to commercialize ANX-530, if an ANX-530 NDA is approved; and other risks and uncertainties more fully describe
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ADVENTRX Receives Refuse to File Letter from FDA on ANX-530 New Drug Application
2. ADVENTRX Announces Management Promotions
3. ADVENTRX Appoints Icahn Representative to Board of Directors
4. ADVENTRX Pharmaceuticals to Present at the 12th Annual BIO CEO & Investor Conference on February 9
5. ADVENTRX Pharmaceuticals to Present at the Lippert/Heilshorn Life Sciences Virtual Conference
6. ADVENTRX Pharmaceuticals Reports Additional Pre-Clinical Data for ANX-514
7. ADVENTRX Pharmaceuticals to Present at the BIOCOM Investor Conference on October 26
8. ADVENTRX Pharmaceuticals Announces Closing of Financing
9. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
10. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
11. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... Calif. , July 27, 2015 Allergan ... (NASDAQ: KYTH ) today announced that the U.S. ... the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... acquisition of KYTHERA.  Logo - http://photos.prnewswire.com/prnh/20150612/222796LOGO ... of Allergan and KYTHERA filed a Pre-Merger Notification and ...
(Date:7/27/2015)... and PITTSBURGH , July 27, 2015 ... it will hold its extraordinary general meeting of shareholders in ... PRGO ; TASE) at the Okura Hotel Amsterdam on ... (CET). Among other agenda items at the ... the approval, under article 2:107a of the Dutch Civil Code, ...
(Date:7/27/2015)...  The fairness of the proposed acquisition of Thoratec ... ("St. Jude") is the subject of an investigation by ... firm.  The investigation is focusing on possible breaches of ... Board of Directors of THOR for agreeing to sell ... Company announced it had reached a definitive agreement for ...
Breaking Medicine Technology:Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 2Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 3Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 4Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 5Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 6Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 7Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 8Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 2Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 3Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 4Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 5Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 6Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 7Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 8Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 9Mylan Announces Meeting Date and Record Date of Extraordinary General Meeting of Shareholders 10WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2
... WILMINGTON, N.C., Oct. 23 PPD, Inc. ... Sydney, Australia;,Copenhagen, Denmark; Lisbon, Portugal; and Lima, Peru; ... key therapeutic areas. The four new offices ... in response to increasing client demand. With,an office ...
... Blueprint for Future, WASHINGTON, Oct. 23 ... latest report from the,Association of Academic Health Centers ... trials in the U.S. and a blueprint for ... academic health,centers nationwide. The infrastructure for clinical trials ...
Cached Medicine Technology:PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal 2AAHC Examines Nation's Clinical Trials Infrastructure 2
(Date:7/28/2015)... , ... July 28, 2015 , ... Intellitec Solutions has ... Today’s annual ranking of Value Added Resellers of ERP Software is a look at ... presented with. This honor represents the second such award in 2015 for Intellitec Solutions, ...
(Date:7/28/2015)... ... July 28, 2015 , ... Carol McFarland, ... with discussion and demonstration of specific rehabilitation exercises and treatment protocols in the ... surgical process with an extensive interview conducted by Carol with a board certified ...
(Date:7/28/2015)... Cupertino, CA (PRWEB) , ... July 28, 2015 ... ... now offering complimentary consultations for Invisalign. Invisalign is a revolutionary orthodontic treatment that ... a combination of Dr. Mozafari’s expertise and 3D computer imaging technology. You wear ...
(Date:7/27/2015)... ... July 28, 2015 , ... Almost a year ago, the ... behavioral health counseling for persons who are obese and those who are overweight with ... , That mandate will affect any commercial health plan with a program year start ...
(Date:7/27/2015)... ... July 27, 2015 , ... Specific ... with smaller regional brain volumes that may be early indicators of Alzheimer’s disease ... “We already know that vascular risk factors damage the brain and can result ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Named by Accounting Today as Top 100 Value Added Reseller 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 2Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 3Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 4Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 5Health News:North American Seminars Introduces a New OT PT PTA Online Continuing Education Course on the Treatment of Post Surgical Cervical and Lumbar Spine Patients 6Health News:Cupertino Invisalign Dentist, Dr. Setareh Mozafari, is Now Offering Complimentary Consultations for Invisalign 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 2Health News:How Digital Therapeutics Can Help Payers Out of Regulatory Fix 3Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 2Health News:RSNA: Specific Cardiovascular Risk Factors May Predict Alzheimer’s Disease 3
... the fifth most common complaint seen in the medical office ... considered a disease of the lungs, organs and tissues of ... tract, or even psychiatric in nature. The common treatments are ... ,A seizure drug may be the answer to quieting ...
... occur each year in the United States. Investigators have been tracking ... years to see how various factors might impact their risk for ... of dementia in those with and without a history of stroke.About ... compared to just 11 percent of those who didn’t have a ...
... improve lifestyle habits may not lower blood pressure in ... ,Researchers investigated whether simple interventions, such as ... intake, and advice for a healthier diet, had more ... 300 patients without an established history of high blood ...
... that about 1 million women in the United ... may encounter // a wide-range of problems while ... that many women find their seizures change in ... menopause. Researchers say hormonal changes may be responsible ...
... diseases such as flu, measles, whooping cough and other ... from coming back. // ,Non-Hodgkin's lymphoma is ... comes back, even after chemotherapy and eventually most of ... their lymphoma. ,The vaccine is made from a ...
... epidemic with the highest incidence rate and a high fatality ... and 299 deaths in a ,population of 6.7 million. ... SARS in Hong Kong. It seems the air may be ... care professionals must take the potential for airborne spread of ...
Cached Medicine News:
Honing compound for knife sharpening, 6 grams net...
Knife sharpening back for Standard Knife, C Profile...
Standard vice clamp, can be fitted instead of Quick Realease Cassette...
... The Cryostage freezing stage is a refrigerated design ... holder, primarily for use with the 8000 sledge ... sledge microtomes. ,The refrigerated stage gives a large ... surface is ridged to provide good adhesion between ...
Medicine Products: